SOUTH SAN FRANCISCO, CA and DEERFIELD, IL, Nov. 5 — (HSMN NewsFeed) - Theravance, Inc. (NASDAQ:THRX ) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV(TM) (telavancin) in the United States. On September 11, 2009, the U.S. Food…
Biopharmaceuticals
Theravance, Astellas Pharma US, VIBATIV, telavancin, cSSSI

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States”
Leave a Comment